SCHEMBL7614102

SCHEMBL7614102

O=C(O)c1cn([C@@H]2C[C@@H]2F)c2cc(N3C[C@@H]4NCCO[C@H]4C3)c(F)cc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
KDM4E B2RXH2 7/20 0.51
LMNA P02545 5/20 0.51
HPGD P15428 5/20 0.51
HSD17B10 Q99714 5/20 0.51
CYP1A2 P05177 1/20 0.51
TOP2A P11388 1/20 0.51
CYP2C9 P11712 1/20 0.51
TOP2B Q02880 1/20 0.51
MAPT P10636 1/20 0.45
HTT P42858 2/20 0.42
BRD4 O60885 1/20 0.42
TSHR P16473 1/20 0.42
CYP2J2 P51589 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TOP1 P11387 2/20 0.40
PIK3CG P48736 4/20 0.40
PIK3CD O00329 3/20 0.40
PIK3R1 P27986 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657864 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL7668621 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL7608332 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL8982890 0.90 KDM4E (0.65) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL8982910 0.90 KDM4E (0.65) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL8982877 0.90 KDM4E (0.65) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL7608342 0.89 ALDH1A1 (0.39) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL7617356 0.89 ALDH1A1 (0.39) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL7614110 0.89 ALDH1A1 (0.39) ALDH1A1KDM4ELMNAHPGDHSD17B10
Hydrochloric Acid SCHEMBL8982744 0.89 KDM4E (0.64) ALDH1A1KDM4ELMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432948-B1 ANTIULCER AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2002-08-13 US disclosed
EP-0946176-B1 THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES BAYER AG (DE) 2002-03-27 EP disclosed
US-6133260-A Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-10-17 US disclosed